GLTO
Galecto Inc
Price Chart
No historical data available
Latest Quote
$28.69
-0.22 (-0.76%)
Current Price
| Previous Close | $28.91 |
| Open | $28.75 |
| Day High | $30.09 |
| Day Low | $26.43 |
| Volume | 231,443 |
Stock Information
| Shares Outstanding | 60.24M |
| Total Debt | $72K |
| Cash Equivalents | $7.61M |
| Net Income | $-15.84M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.73B |
| EPS (TTM) | $-12.11 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Galecto Inc
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.
đ° Latest News
Galecto (GLTO) Is Up 15.3% After $316 Million Equity Raise And New Shelf Registration - What's Changed
Simply Wall St. âĸ 2026-02-16T03:13:14Z
Assessing Galecto (GLTO) Valuation After Sharp Short-Term Share Price Momentum
Simply Wall St. âĸ 2026-02-15T17:08:53Z
Wayfair upgraded, Instacart initiated: Wall Street's top analyst calls
The Fly âĸ 2026-01-07T14:41:07Z
Metagenomi, Ovid CEOs step aside; Cogent soars on âunprecedentedâ stomach cancer data
BioPharma Dive âĸ 2025-11-12T10:20:00Z
This Penny Stock Just Quadrupled. Should You Buy It Now?
Barchart âĸ 2025-11-10T21:05:04Z
POET Technologies, Oracle, Nuburu, Galecto And TMC The Metals Company: Why These 5 Stocks Are On Investors' Radars Today
Benzinga âĸ 2025-10-09T15:24:49Z
This Penny Stock Just Jumped 750%. Can It Retain These Gains for the Long Term?
Barchart âĸ 2025-10-07T20:43:12Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $21,292,000 | $36,457,000 | $61,207,000 | $52,227,000 |
| Other Income Expense | $-950,000 | $-3,581,000 | $-1,139,000 | $319,000 |
| Net Non Operating Interest Income Expense | $844,000 | $1,689,000 | $722,000 | $156,000 |
| Operating Expense | $21,292,000 | $36,457,000 | $61,207,000 | $52,227,000 |
| General And Administrative Expense | $10,499,000 | $12,687,000 | $13,001,000 | $13,739,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-21,439,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Net Interest Income | $844,000 | $1,689,000 | $722,000 | $156,000 |
| Interest Income | $844,000 | $1,689,000 | $722,000 | $156,000 |
| Normalized Income | $-20,489,000 | $-34,768,000 | $-60,485,000 | $-52,071,000 |
| Net Income From Continuing And Discontinued Operation | $-21,439,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Total Operating Income As Reported | $-22,260,000 | $-39,905,000 | $-61,207,000 | $-52,227,000 |
| Net Income Common Stockholders | $-21,439,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Net Income | $-21,439,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Net Income Including Noncontrolling Interests | $-21,439,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Net Income Continuous Operations | $-21,439,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Pretax Income | $-21,398,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Special Income Charges | $-968,000 | $-3,384,000 | $0 | - |
| Interest Income Non Operating | $844,000 | $1,689,000 | $722,000 | $156,000 |
| Operating Income | $-21,292,000 | $-36,457,000 | $-61,207,000 | $-52,227,000 |
| Per Share | ||||
| Diluted EPS | $-18.53 | $-36.08 | $-60.75 | $-51.25 |
| Basic EPS | $-18.53 | $-36.08 | $-60.75 | $-51.25 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-20,161,000 | $-32,046,000 | $-59,578,000 | $-52,105,000 |
| Total Unusual Items | $-950,000 | $-3,581,000 | $-1,139,000 | $319,000 |
| Total Unusual Items Excluding Goodwill | $-950,000 | $-3,581,000 | $-1,139,000 | $319,000 |
| Reconciled Depreciation | $181,000 | $830,000 | $490,000 | $441,000 |
| EBITDA (Bullshit earnings) | $-21,111,000 | $-35,627,000 | $-60,717,000 | $-51,786,000 |
| EBIT | $-21,292,000 | $-36,457,000 | $-61,207,000 | $-52,227,000 |
| Diluted Average Shares | $1,157,149 | $1,062,873 | $1,016,364 | $1,010,473 |
| Basic Average Shares | $1,157,149 | $1,062,873 | $1,016,364 | $1,010,473 |
| Diluted NI Availto Com Stockholders | $-21,439,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Tax Provision | $41,000 | $0 | - | - |
| Gain On Sale Of Ppe | $0 | $64,000 | $0 | - |
| Restructuring And Mergern Acquisition | $968,000 | $3,448,000 | $0 | - |
| Gain On Sale Of Security | $18,000 | $-197,000 | $-1,139,000 | $319,000 |
| Research And Development | $10,793,000 | $23,770,000 | $48,206,000 | $38,488,000 |
| Selling General And Administration | $10,499,000 | $12,687,000 | $13,001,000 | $13,739,000 |
| Other Gand A | $10,499,000 | $12,687,000 | $13,001,000 | $13,739,000 |
Fetched: 2026-03-10
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $15,831,000 | $32,331,000 | $61,753,000 | $117,223,000 |
| Total Assets | $17,132,000 | $38,227,000 | $73,188,000 | $122,215,000 |
| Total Non Current Assets | $293,000 | $1,453,000 | $9,278,000 | $12,113,000 |
| Other Non Current Assets | $163,000 | $1,128,000 | $2,279,000 | $2,028,000 |
| Current Assets | $16,839,000 | $36,774,000 | $63,910,000 | $110,102,000 |
| Other Current Assets | $90,000 | $85,000 | $52,000 | $334,000 |
| Current Deferred Assets | $1,103,000 | $1,046,000 | $1,450,000 | $5,569,000 |
| Prepaid Assets | $590,000 | $774,000 | $805,000 | $1,728,000 |
| Receivables | $881,000 | $1,718,000 | $1,379,000 | $2,280,000 |
| Taxes Receivable | $881,000 | $1,718,000 | $1,379,000 | $2,280,000 |
| Cash Cash Equivalents And Short Term Investments | $14,175,000 | $33,151,000 | $60,224,000 | $100,191,000 |
| Cash And Cash Equivalents | $14,175,000 | $21,465,000 | $32,786,000 | $62,563,000 |
| Investmentin Financial Assets | - | $0 | $5,832,000 | $9,048,000 |
| Debt | ||||
| Total Debt | $73,000 | $249,000 | $804,000 | $847,000 |
| Long Term Debt And Capital Lease Obligation | $61,000 | $66,000 | $328,000 | $448,000 |
| Current Debt And Capital Lease Obligation | $12,000 | $183,000 | $476,000 | $399,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,301,000 | $5,896,000 | $11,435,000 | $4,992,000 |
| Total Non Current Liabilities Net Minority Interest | $104,000 | $66,000 | $328,000 | $448,000 |
| Other Non Current Liabilities | $43,000 | - | - | - |
| Current Liabilities | $1,197,000 | $5,830,000 | $11,107,000 | $4,544,000 |
| Other Current Liabilities | $487,000 | $539,000 | $539,000 | $438,000 |
| Payables And Accrued Expenses | $494,000 | $4,121,000 | $9,495,000 | $3,106,000 |
| Payables | $377,000 | $1,702,000 | $3,350,000 | $1,531,000 |
| Accounts Payable | $377,000 | $1,702,000 | $3,350,000 | $1,531,000 |
| Equity | ||||
| Common Stock Equity | $14,471,000 | $32,331,000 | $61,753,000 | $117,223,000 |
| Preferred Stock Equity | $1,360,000 | - | - | - |
| Total Equity Gross Minority Interest | $15,831,000 | $32,331,000 | $61,753,000 | $117,223,000 |
| Stockholders Equity | $15,831,000 | $32,331,000 | $61,753,000 | $117,223,000 |
| Gains Losses Not Affecting Retained Earnings | $97,000 | $380,000 | $-244,000 | $-320,000 |
| Other Equity Adjustments | $97,000 | $380,000 | $-244,000 | $-320,000 |
| Retained Earnings | $-277,524,000 | $-256,085,000 | $-217,736,000 | $-156,112,000 |
| Other | ||||
| Ordinary Shares Number | $1,316,989 | $1,084,507 | $1,026,095 | $1,010,473 |
| Share Issued | $1,316,989 | $1,084,507 | $1,026,095 | $1,010,473 |
| Tangible Book Value | $14,471,000 | $32,331,000 | $61,753,000 | $117,223,000 |
| Invested Capital | $14,471,000 | $32,331,000 | $61,753,000 | $117,223,000 |
| Working Capital | $15,642,000 | $30,944,000 | $52,803,000 | $105,558,000 |
| Capital Lease Obligations | $73,000 | $249,000 | $804,000 | $847,000 |
| Total Capitalization | $15,831,000 | $32,331,000 | $61,753,000 | $117,223,000 |
| Additional Paid In Capital | $291,898,000 | $288,036,000 | $279,733,000 | $273,655,000 |
| Capital Stock | $1,360,000 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Preferred Stock | $1,360,000 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $61,000 | $66,000 | $328,000 | $448,000 |
| Current Capital Lease Obligation | $12,000 | $183,000 | $476,000 | $399,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $204,000 | $987,000 | $597,000 | $601,000 |
| Current Accrued Expenses | $117,000 | $2,419,000 | $6,145,000 | $1,575,000 |
| Net PPE | $130,000 | $325,000 | $1,167,000 | $1,037,000 |
| Accumulated Depreciation | $-50,000 | $-29,000 | $-62,000 | $-20,000 |
| Gross PPE | $180,000 | $354,000 | $1,229,000 | $1,057,000 |
| Other Properties | $180,000 | $354,000 | $1,229,000 | $1,057,000 |
| Other Short Term Investments | $0 | $11,686,000 | $27,438,000 | $37,628,000 |
| Investments And Advances | - | $0 | $5,832,000 | $9,048,000 |
| Other Investments | - | - | $5,832,000 | $9,048,000 |
| Available For Sale Securities | - | - | $5,832,000 | $9,048,000 |
| Machinery Furniture Equipment | - | - | - | $223,000 |
Fetched: 2026-03-10
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-18,623,000 | $-36,911,000 | $-43,128,000 | $-52,531,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-18,623,000 | $-36,911,000 | $-42,932,000 | $-52,308,000 |
| Cash Flow From Continuing Operating Activities | $-18,623,000 | $-36,911,000 | $-42,932,000 | $-52,308,000 |
| Operating Gains Losses | - | $-64,000 | $70,000 | - |
| Investing Activities | ||||
| Investing Cash Flow | $11,650,000 | $22,330,000 | $12,384,000 | $-48,048,000 |
| Cash Flow From Continuing Investing Activities | $11,650,000 | $22,330,000 | $12,384,000 | $-48,048,000 |
| Capital Expenditure | - | - | $-196,000 | $-223,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $2,876,000 | $507,000 | $0 |
| Financing Cash Flow | $0 | $2,876,000 | $507,000 | $0 |
| Cash Flow From Continuing Financing Activities | $0 | $2,876,000 | $507,000 | $0 |
| Net Common Stock Issuance | $0 | $2,876,000 | $507,000 | $0 |
| Common Stock Issuance | $0 | $2,876,000 | $507,000 | $0 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $14,175,000 | $21,465,000 | $32,786,000 | $62,563,000 |
| Beginning Cash Position | $21,465,000 | $32,786,000 | $62,563,000 | $163,836,000 |
| Effect Of Exchange Rate Changes | $-317,000 | $384,000 | $264,000 | $-917,000 |
| Changes In Cash | $-6,973,000 | $-11,705,000 | $-30,041,000 | $-100,356,000 |
| Net Investment Purchase And Sale | $11,650,000 | $22,247,000 | $12,580,000 | $-47,825,000 |
| Sale Of Investment | $11,650,000 | $48,184,000 | $57,445,000 | $36,384,000 |
| Purchase Of Investment | $0 | $-25,937,000 | $-44,865,000 | $-84,209,000 |
| Net PPE Purchase And Sale | $0 | $83,000 | $-196,000 | $-223,000 |
| Sale Of PPE | $0 | $83,000 | $0 | - |
| Change In Working Capital | $-2,667,000 | $-4,370,000 | $11,937,000 | $-6,624,000 |
| Change In Other Current Liabilities | $-127,000 | $-600,000 | $-523,000 | $-513,000 |
| Change In Other Current Assets | $970,000 | $1,148,000 | $-257,000 | $-866,000 |
| Change In Payables And Accrued Expense | $-4,464,000 | $-4,983,000 | $6,485,000 | $-1,046,000 |
| Change In Accrued Expense | $-3,139,000 | $-3,335,000 | $4,666,000 | $274,000 |
| Change In Payable | $-1,325,000 | $-1,648,000 | $1,819,000 | $-1,320,000 |
| Change In Account Payable | $-1,325,000 | $-1,648,000 | $1,819,000 | $-1,320,000 |
| Change In Prepaid Assets | $954,000 | $65,000 | $6,232,000 | $-4,199,000 |
| Other Non Cash Items | $1,993,000 | $46,000 | $58,000 | $75,000 |
| Stock Based Compensation | $3,239,000 | $5,427,000 | $5,571,000 | $4,480,000 |
| Amortization Of Securities | $70,000 | $-431,000 | $566,000 | $1,072,000 |
| Depreciation Amortization Depletion | $181,000 | $830,000 | $490,000 | $441,000 |
| Depreciation And Amortization | $181,000 | $830,000 | $490,000 | $441,000 |
| Depreciation | $181,000 | $830,000 | $490,000 | $441,000 |
| Gain Loss On Sale Of PPE | $0 | $-64,000 | $0 | - |
| Net Income From Continuing Operations | $-21,439,000 | $-38,349,000 | $-61,624,000 | $-51,752,000 |
| Purchase Of PPE | - | $0 | $-196,000 | $-223,000 |
| Gain Loss On Investment Securities | - | - | $70,000 | - |
| Proceeds From Stock Option Exercised | - | - | - | $0 |
Fetched: 2026-03-10